Could where you live dictate how long you live? New research at Syracuse University's Maxwell School, published today in the Milbank Quarterly, shows Americans who live in so-called blue states tend to live longer than those in red states, primarily due to state policies.
Emphysema is a progressive, debilitating lung disease in which the lung's breathing sacs, or alveoli, enlarge, get thinner, and eventually are destroyed as the cells die off. It can be fatal, and there is currently no cure. New research at Boston Children's Hospital, using lung cells and mouse models of emphysema, offers hope in the form of a small, engineered peptide molecule called PR1P.
After tracking a cohort of community members equipped with naloxone and a smartphone application for more than a year, researchers showed that laypersons can effectively signal and respond to overdose incident to administer nasal naloxone in advance of emergency medical service (EMS) arrival. Just as CPR and early defibrillation administered by laypersons in advance of EMS contribute to positive outcomes after cardiac arrest, so, too, can opioid patients benefit from similar forms of community support.
A common green apple vape flavor enhances nicotine reward and is also rewarding itself, according to research in mice recently published in eNeuro.
Behavioral and nicotine replacement therapies offered together can help people who are incarcerated quit smoking, according to Rutgers researchers.
Forty percent of dementia cases could be prevented or delayed by targeting 12 risk factors throughout life, experts say.
Modifying 12 risk factors over the lifecourse could delay or prevent 40% of dementia cases, according to an update to The Lancet Commission on dementia prevention, intervention, and care, which is being presented at the Alzheimer's Association International Conference (AAIC 2020).
Smokers who have thoracic surgery are much more likely to stop using tobacco if they also complete a quitline intervention, a new UC Davis Health study shows.
Prescription medication of cannabis extract cannabidiol, or CBD, is safe for daily use in treating cannabis use disorder, and could help people to cut down on cannabis use, according to an initial randomised controlled trial published in The Lancet Psychiatry journal.
A benchmark clinical trial published today shows that cannabidiol (CBD) could be a safe and effective treatment for problematic cannabis use.